Fundraising Fox

DelNova

Highland, US · Founded 2016 · 1 known investors

delnova.net

DelNova is a life science company developing proprietary assets in medical aesthetics and neuromuscular therapeutics, having advanced from early research into Series A financing. Its work relates to injectable aesthetics such as neurotoxins and peripheral nerve applications.

BiotechHealthtechMedical Devices

Founders & leadership

DelNova was founded in 2016 by Mary Gardner.

MGMary Gardner
Mary GardnerinChief Executive Officer & Founder
SB
Sameer B. ShahChief Scientist
SY
Steven YoelinChief Medical Strategist
DJ
Dimas JimenezChief Financial Advisor

Board

DB
Daniel BradburyBoard director

Investors · 1

Reported raises · per SEC filings

Form D private placements

$810.2K disclosed across 1 round · 2018

$810.2KraisedApr 2018 · 3 investors · Other
Rule 506(b)
Officers, directors & promoters on the filing
  • Daniel BradburyDirector
  • Mary GardnerExecutive Officer, Director
Offering amount
$1M
Amount sold
$810.2K
First sale
Mar 2018
Incorporated
Corporation, Delaware, 2016
Federal exemptions
06b
Full filing on SEC EDGAR ↗

Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.

Competitors · 2

by search overlap

Companies competing with DelNova for the same Google search keywords, organic and paid, via search-intersection analysis.

Frequently asked questions

What does DelNova do?
DelNova is a life science company developing proprietary assets in medical aesthetics and neuromuscular therapeutics, having advanced from early research into Series A financing. Its work relates to injectable aesthetics such as neurotoxins and peripheral nerve applications.
Who founded DelNova?
DelNova was founded by Mary Gardner in 2016.
Who are DelNova's investors?
DelNova's investors include BioBrit.
How much funding has DelNova raised?
DelNova has disclosed $810.2K raised across 1 round.
Where is DelNova headquartered?
DelNova is headquartered in Highland, US.